8H57
Crystal Structure of SARS-CoV-2 Main Protease (Mpro) A193P Mutant in Complex with Inhibitor Nirmatrelvir
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I04 |
Synchrotron site | Diamond |
Beamline | I04 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2022-08-10 |
Detector | DECTRIS EIGER2 X 16M |
Wavelength(s) | 0.953740 |
Spacegroup name | P 21 21 2 |
Unit cell lengths | 45.399, 63.974, 105.469 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 27.800 - 1.550 |
R-factor | 0.1784 |
Rwork | 0.177 |
R-free | 0.20380 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 7vh8 |
Data reduction software | autoPROC |
Data scaling software | XSCALE |
Phasing software | PHENIX |
Refinement software | PHENIX (1.19.2_4158) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 27.800 | 27.800 | 1.650 |
High resolution limit [Å] | 1.550 | 4.610 | 1.550 |
Rmerge | 0.069 | 0.034 | 0.646 |
Rmeas | 0.071 | 0.036 | 0.670 |
Total number of observations | 607884 | ||
Number of reflections | 44743 | 1883 | 7054 |
<I/σ(I)> | 22.61 | 69.32 | 3.71 |
Completeness [%] | 99.1 | 98.4 | 98.4 |
Redundancy | 13.586 | 12.984 | 13.944 |
CC(1/2) | 1.000 | 0.999 | 0.924 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | EVAPORATION | 293 | 0.05% w/v D-Salicin, 0.05% w/v Esculin hydrate, 0.05% w/v Quinine hemisulfate salt monohydrate, 0.05% w/v Tryptamine, 0.05% w/v Arbutin, 0.1 M Buffer System 2 pH 7.5 (sodium HEPES, MOPS acid), 20% v/v ethylene glycol, 10% w/v PEG 8,000 |